XML 310 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Expense Share-based compensation expense is included in selling, general, and administrative expenses in the Consolidated Statements of Operations and was as follows:
Years Ended December 31,
(in thousands)
202120202019
Share-based compensation expense$61,237 $96,013 $85,626 
Summary of Distributed Shares Activity
The following table summarizes activity related to the Distributed Shares during 2021:
Performance Tranche
Number of Distributed SharesWeighted-Average Grant Fair Value
Unvested as of December 31, 20209,583,754 $13.10 
Vested— — 
Forfeited(80,086)13.42 
Unvested as of December 31, 20219,503,668 $13.08 
Summary of Related 2018 Plan Top-up Options Activity
The following table summarizes activity related to the 2018 Plan Top-up Options:
Service TranchePerformance Tranche
Number of Top-up OptionsWeighted-Average Exercise PriceNumber of Top-up OptionsWeighted-Average Exercise Price
Aggregate Intrinsic Value(a)
(in thousands)
Weighted-Average Remaining Contractual Term (Years)
Outstanding as of December 31, 20205,974,369 $13.30 5,923,973 $13.30 
Exercised— — — — 
Forfeited— — (73,424)13.30 
Outstanding as of December 31, 20215,974,369 $13.30 5,850,549 $13.30 — 6.0
Exercisable as of December 31, 20215,974,369 $13.30 — $13.30 — 6.0
________________________
(a)The intrinsic value represents the amount by which the fair value of the Company’s Common Stock exceeds the option exercise price as of December 31, 2021.
The following table summarizes activity related to 2018 Plan options during 2021:
Number of OptionsWeighted-Average Exercise Price
Aggregate Intrinsic Value(a)
(in thousands)
Weighted-Average Remaining Contractual Term
(Years)
Outstanding as of December 31, 202024,191,120 $6.60 
Granted— — 
Exercised(1,951,552)5.55 
Forfeited(773,750)7.49 
Outstanding as of December 31, 202121,465,818 $6.64 $50,657 7.2
Exercisable as of December 31, 202110,611,711 $8.33 $19,089 6.8
________________________
(a)The intrinsic value represents the amount by which the fair value of the Company’s Common Stock exceeds the option exercise price as of December 31, 2021.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions During 2020 and 2019, the grant date fair values of options granted under the 2018 Plan were determined using the Black-Scholes valuation approach with the following assumptions:
Years Ended December 31,
20202019
Risk-free interest rate0.51% - 1.40%1.58% - 2.51%
Expected exercise term (years)66.0 - 6.5
Expected dividend yield2.2% - 2.7%2.0% - 2.7%
Expected volatility45% - 46%41% - 42%
Summary of Related 2018 Plan RSUs Activity
The following table summarizes activity related to the 2018 Plan RSUs (including DEUs) during 2021:
Number of RSUsWeighted-Average Grant Date Fair Value
Unvested as of December 31, 202016,763,274 $6.56 
Granted6,585,882 8.09 
Vested(6,481,391)7.14 
Forfeited(1,322,919)7.32 
Unvested as of December 31, 202115,544,846 $6.90